Omalizumab Demonstrates Effectiveness in Normocomplementemic Urticarial Vasculitis
Investigators characterized the effects and markers of response of omalizumab in normocomplementemic urticarial vasculitis.
Investigators characterized the effects and markers of response of omalizumab in normocomplementemic urticarial vasculitis.
Risk factors related to the development of a second primary melanoma have been identified and may aid in determining melanoma guidelines and prevention strategies.
Allergen-specific immunotherapy using animal dander may effectively treat atopic dermatitis.
A concentration of minoxidil and carboxygas can incite lasting hair growth in patients with androgenic alopecia.
Investigators evaluated the therapeutic effect of a 1540-nm nonablative fractional laser on actinic keratosis, which can be treated by various treatment modalities.
Investigators sought to determine whether cryopeeling provided faster and superior improvement of solar lentigines than trichloroacetic acid 35% peeling.
The prevalence of acute posttraumatic stress symptoms in the study population was 4.6%, ranging from 4.4% in healthcare workers to 518.4% in the high-risk general population.
Treatment with dupilumab in patients with moderate to severe atopic dermatitis was found to be effective in 54% of patients—a percentage that may reflect use of adjunctive therapies.
Researchers examined the relationship between vitiligo and the risk for psychiatric disorders such as anxiety, major depressive disorder, and manic disorders.
A deep learning model trained to predict antibiotics based on structure has identified a powerful new antibiotic compound, Halicin, according to study results published in Cell.